After the Rally: Pfizer's COVID Booster vs. O...

We bring you full coverage of the historic SpaceX IPO as it opens for trade at the Nasdaq. Plus, we speak exclusively with the second largest shareholder in SpaceX after Elon Musk, Antonio Gracias of Valor Equity Partners. We also bring you an exclusive interview with early Space ...  Show more

Full coverage of the leadup to the first trade of SpaceX. Live from the Nasdaq, the Morgan Stanley trading floor, and the New York Stock Exchange. We speak with some of the top SpaceX shareholders as well and industry experts to make sense of SpaceX’s debut and its valuation. Squ ...  Show more

Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF. Bloomberg Technology Co-Host Ed Ludlow discusses Tesla easing concerns about disappointing earnings results and diminished growth by vowing to launch less-expensive vehicles as soon as late this year. Bloomberg ...  Show more

DB-Dec08,2021:With markets easing on Omicron fears this week and assets across the board beginning to recover from last week’s drawdowns, Pfizer and BioNTech both announced today the initial findings of the effectiveness of their boosters against the Omicron variant, demonstratin ...  Show more

CNBC’s Brian Sullivan reports on the EV race. Ford might be hitting the brakes for now, but one unexpected company is in the fast lane. Cisco reported better-than-expected fiscal second-quarter results and lifted its forecast for the full year. Plus, Capital Wealth Planning’s ...

Meta dropping after-hours as guidance disappoints. So has the social stock’s recent climb come to an end? Plus Investors plug into Tesla post-earnings, as CEO Elon Musk gives updates on the EV maker’s new models and robotaxi plans. What he’s saying about the timeline and if th ...